Hilary M. Collins - Concepedia

Author

Hilary M. Collins

Also Known As

Collins, Hilary, H Collins, H M Collins, H. M. Collins, H.M. Collins, HM Collins, Hilary Collins, Hilary M Collins, Hilary M. Collins

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

University of Nottingham University of Nottingham Malaysia Campus Queen's Medical Centre Lund University Umeå University

About

Hilary M. Collins is an author at University of Nottingham specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	1.2K
2	Natural Sciences	4	4	88
3	Engineering	3	3	525
4	Biochemistry	2	2	37
5	Health Sciences	1	1	26

Hilary M. Collins

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Global Histone Modifications in Breast Cancer Correlate with Tumor Phenotypes, Prognostic Factors, and Patient Outcome Somaia Elsheikh, Andrew R. Green, Emad A. Rakha, Cancer Research Histone ModificationsBreast OncologyEngineeringEpigenetic ChangeMethylation Marks	2009	497
Matrix metalloproteinases Simon L. Parsons, Susan A. Watson, Peter de Nully Brown, British journal of surgery Tumor BiologyGastrointestinal OncologyMedicineMatrix MetalloproteinasesImmunology	1997	266
Matrix metalloproteinases Simon L. Parsons, Susan A. Watson, Peter de Nully Brown, British journal of surgery	1997	230
p38 MAPK/MK2-mediated induction of miR-34c following DNA damage prevents Myc-dependent DNA replication Ian G. Cannell, Yi Wen Kong, Samantha J. Johnston, Proceedings of the National Academy of Sciences	2010	170
The double PHD finger domain of MOZ/MYST3 induces α-helical structure of the histone H3 tail to facilitate acetylation and methylation sampling and modification Ingrid Dreveny, S.E. Deeves, Joel Fulton, Nucleic Acids Research	2013	98
Differential effects of garcinol and curcumin on histone and p53 modifications in tumour cells Hilary M. Collins, Magdy K. Abdelghany, Marie C. Messmer, BMC Cancer	2013	93
Matrix Metalloproteinases Simon L. Parsons, Susan A. Watson, P D Brown, Science Signaling	2000	80
An Apoferritin‐based Drug Delivery System for the Tyrosine Kinase Inhibitor Gefitinib Anchala I. Kuruppu, Lei Zhang, Hilary M. Collins, Advanced Healthcare Materials	2015	71
MOZ-TIF2 Inhibits Transcription by Nuclear Receptors and p53 by Impairment of CBP Function Karin B. Kindle, Philip J.F. Troke, Hilary M. Collins, Molecular and Cellular Biology Molecular RegulationMixed-phenotype Acute LeukemiaMyeloid NeoplasiaHematological MalignancyTranscriptional Regulation	2005	59
Lipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system Jong Bong Lee, Atheer Zgair, Jed Malec, Journal of Controlled Release Lipid PreparationCell-based Drug DeliveryMedicinal ChemistryProdrug ApproachPolymer-drug Conjugate	2018	57

Page 1